Recruiting NA Dyssynergic Defaecation

Tests treatment safety and results for Dyssynergic Defaecation

Official title Efficacy of Cognitive Behavioral Therapy Administered in Patients With Dyssynergic Defecation

ClinicalTrials.gov ID: NCT07488442

What this study is testing

What it's testing
The aim of this study is to evaluate the effectiveness of cognitive-behavioral therapy when used in conjunction with lifestyle modifications and pelvic floor rehabilitation.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 55

You may be able to join if

  • A history of constipation lasting longer than one year
  • Chronic constipation as defined by the Rome IV criteria
  • Being between the ages of 18 and 55
  • Findings consistent with dyssynergic defecation on anorectal manometry and balloon defecography
  • Exclusion of organic and metabolic causes of chronic constipation

You likely can't join if

  • Active bowel disease
  • Presence of an active anal fissure
  • History of major abdominal surgery
  • Presence of a neurological disorder
  • Presence of a serious psychiatric disorder
  • Use of medications that cause constipation

The study team makes the final eligibility decision.

Where it's taking place

  • Ankara, Yenimahalle, Turkey (Türkiye)

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 55 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Ankara, Yenimahalle, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.